Fuente: Nutraingredients Usa Lugar: Research Totality Biosciences is pioneering a synthetic biology platform using GMO plants to produce the full spectrum of human milk oligosaccharides (HMOs), potentially reducing costs by an order of magnitude and expanding access beyond the limited HMOs currently made via microbial fermentation. The company, a Probiota Pioneer, will showcase how plant-based HMO production could transform infant formula, gut health, and prebiotic applications at the upcoming IPA World Congress + Probiota 2026.